Literature DB >> 11160756

Self-association and mapping of the interaction domain of hepatitis E virus ORF3 protein.

S Tyagi1, S Jameel, S K Lal.   

Abstract

Hepatitis E virus (HEV) is a major human pathogen in the developing world. In the absence of an in vitro culture system, very little information on the basic biology of the virus exists. A small protein (approximately 13.5 kDa) of unknown function, pORF3, is encoded by the third open reading frame of HEV. The N-terminal region of pORF3 is associated with the cytoskeleton using one of its hydrophobic domains. The C-terminal half of pORF3 is rich in proline residues and contains a putative src homology 3 (SH3) binding domain and a mitogen-activated protein kinase phosphorylation site. In this study, we demonstrate that pORF3 can homodimerize in vivo, using the yeast two-hybrid system. We have isolated a 43-amino-acid interaction domain of pORF3 which is capable of self-association in vivo and in vitro. The overlap of the dimerization domain with the SH3 binding and phosphorylation domains suggests that pORF3 may have a dimerization-dependent regulatory role to play in the signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160756      PMCID: PMC114836          DOI: 10.1128/JVI.75.5.2493-2498.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Combined transformation and genetic technique verification of protein-protein interactions in the yeast two-hybrid system.

Authors:  S Tyagi; S K Lal
Journal:  Biochem Biophys Res Commun       Date:  2000-11-02       Impact factor: 3.575

2.  Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1).

Authors:  I H Ansari; S K Nanda; H Durgapal; S Agrawal; S K Mohanty; D Gupta; S Jameel; S K Panda
Journal:  J Med Virol       Date:  2000-03       Impact factor: 2.327

Review 3.  Enterically-transmitted non-A, non-B hepatitis.

Authors:  D W Bradley
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

4.  The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious.

Authors:  S K Panda; I H Ansari; H Durgapal; S Agrawal; S Jameel
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Augmentation of immune responses to hepatitis E virus ORF2 DNA vaccination by codelivery of cytokine genes.

Authors:  R Tuteja; T C Li; N Takeda; S Jameel
Journal:  Viral Immunol       Date:  2000       Impact factor: 2.257

6.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

7.  Incidence and severity of viral hepatitis in pregnancy.

Authors:  M S Khuroo; M R Teli; S Skidmore; M A Sofi; M I Khuroo
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

8.  Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology.

Authors:  D C Wong; R H Purcell; M A Sreenivasan; S R Prasad; K M Pavri
Journal:  Lancet       Date:  1980-10-25       Impact factor: 79.321

9.  Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type.

Authors:  M S Khuroo
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

10.  Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome.

Authors:  A W Tam; M M Smith; M E Guerra; C C Huang; D W Bradley; K E Fry; G R Reyes
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

View more
  17 in total

1.  Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay.

Authors:  C Yu; R E Engle; J P Bryan; S U Emerson; R H Purcell
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

3.  In vitro and in vivo mutational analysis of the 3'-terminal regions of hepatitis e virus genomes and replicons.

Authors:  Judith Graff; Hanh Nguyen; Chaiyan Kasorndorkbua; Patrick G Halbur; Marisa St Claire; Robert H Purcell; Suzanne U Emerson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo.

Authors:  Y W Huang; T Opriessnig; P G Halbur; X J Meng
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

Review 5.  Hepatitis e: molecular virology and pathogenesis.

Authors:  Subrat K Panda; Satya P K Varma
Journal:  J Clin Exp Hepatol       Date:  2013-05-30

Review 6.  Stem Cell-Derived Culture Models of Hepatitis E Virus Infection.

Authors:  Viet Loan Dao Thi; Xianfang Wu; Charles M Rice
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

7.  The 41-amino-acid C-terminal region of the hepatitis E virus ORF3 protein interacts with bikunin, a kunitz-type serine protease inhibitor.

Authors:  Shweta Tyagi; Milan Surjit; Sunil K Lal
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  RNA interference induces effective inhibition of mRNA accumulation and protein expression of SHEV ORF3 gene in vitro.

Authors:  Tao Liu; Ming Lei; Hanwei Jiao; Li Du; Ying Cheng; Donglin Zhang; Yongchang Hao; Churiga Man; Fengyang Wang
Journal:  Curr Microbiol       Date:  2011-01-12       Impact factor: 2.188

9.  The ORF2 protein of hepatitis E virus binds the 5' region of viral RNA.

Authors:  Milan Surjit; Shahid Jameel; Sunil K Lal
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Replacement of the hepatitis E virus ORF3 protein PxxP motif with heterologous late domain motifs affects virus release via interaction with TSG101.

Authors:  Scott P Kenney; Jacquelyn L Wentworth; Connie L Heffron; Xiang-Jin Meng
Journal:  Virology       Date:  2015-10-27       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.